about
Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.Fluorescent analogs of trypsin inhibitor SFTI-1 isolated from sunflower seeds--synthesis and applications.Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections.CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients.Impact of donor and recipient human cytomegalovirus status on kidney transplantation.Identification of patients with increased immunological risk among potential kidney recipients in the Polish population.Algorithm to manage highly sensitized kidney transplant recipients in Poland.CD4+CD25highCD127low/−FoxP3+ Regulatory T Cell Subpopulations in the Bone Marrow and Peripheral Blood of Children with ALL: Brief Report.CD4CD25CD127FoxP Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature[Application of basophil activation test in diagnosing aspirin hypersensitivity]In Vitro Evaluation of the Allergic Potential of Antibacterial Peptides: Camel and CitropinPeripheral regulatory T cells and anti-inflammatory cytokines in children with juvenile idiopathic arthritisPeripheral and Intestinal T-regulatory Cells are Upregulated in Children with Inflammatory Bowel Disease at Onset of DiseaseCD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke PatientsProinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapyEvaluation of Pretransplant Donor-Specific Alloantibodies With Different Crossmatch TechniquesCXCR7+ and CXCR4+ stem cells and neuron specific enolase in acute ischemic stroke patientsRegulatory T cells: the future of autoimmune disease treatmentChanging microRNA Expression during Three-Month Wasp Venom Immunotherapy
P50
Q35664105-118BFC4D-DB71-4B6A-9821-B4C1482E0C92Q37460801-3EDE7393-6BC0-4B84-999C-3080CA8C3428Q39056052-87B6222D-41C1-46DA-A881-2A09DF468D39Q40362665-3DA9E841-EB12-4A1F-9E2D-651608DEF67EQ40575410-8962B1A1-B586-4871-88EB-55015C4067F5Q47585004-E8DA0B5E-AAE2-4E0C-8B49-1C80597ABADBQ51091773-9E27DFC8-C28A-4A70-AC88-9965D0BED009Q51519866-A1E2F1D3-79F3-48D0-83D3-2867E707124FQ55554970-8752CA66-9B09-471F-9C64-74A94D4941C2Q64071265-04426991-898B-4FE5-9186-7380681536CCQ86507458-CDD6F4A3-9D7F-4CC4-83F0-8707A03866BEQ86714944-2C7DB396-B675-4A6B-AC23-FB5F501DFE31Q87922638-F81782E0-5CBA-4DBE-91C8-89A3DD06753DQ88586428-5A9EA11F-15AF-4879-B26C-CA3FDF8AAD96Q88622370-893B4D7C-949C-4B96-856B-63635EE60D00Q89881919-D5841FD6-E1DE-4CD7-9473-0BBAB706072CQ90595479-10C37594-BACC-4BA3-94A7-B204A661DC3BQ91040607-E32225FA-7051-41CE-9FD3-FE64BD06415DQ92141055-17AA8468-F66D-4059-954F-7CB6B2B986DAQ92248126-0841D39A-E930-4A98-A369-ABC0CC88FDE4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maciej Zielinski
@ast
Maciej Zielinski
@en
Maciej Zielinski
@es
Maciej Zielinski
@nl
type
label
Maciej Zielinski
@ast
Maciej Zielinski
@en
Maciej Zielinski
@es
Maciej Zielinski
@nl
prefLabel
Maciej Zielinski
@ast
Maciej Zielinski
@en
Maciej Zielinski
@es
Maciej Zielinski
@nl
P106
P1153
54890479100
P31
P496
0000-0002-8366-5846